Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All quercetin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease

Xu et al., Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2309870120
Sep 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
23rd treatment shown to reduce risk in July 2021
 
*, now with p = 0.0031 from 11 studies.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,500+ studies for 81 treatments. c19early.org
In Vitro study1 and associated response from the original authors2, collectively showing that quercetin and echinatin had weak SARS-CoV-2 protease inhibition in SDS-PAGE assays2, despite false positive FRET results from MCA-AVLQ quenching1,2. Authors note that the compounds may act via other targets to achieve reported anti-COVID-19 effects2, and underscore the importance of meticulous validation with multiple assays when identifying SARS-CoV-2 protease inhibitors1,2.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
59 preclinical studies support the efficacy of quercetin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,4,5,17,19,20,25,33,34,36,37,54,55, MproB,4,6,8,10,12,13,15,18,19,25,29,31-33,37,38,40,55,56, RNA-dependent RNA polymeraseC,4,27, PLproD,32,40, ACE2E,17,18,23,32,36,55, TMPRSS2F,17, helicaseG,24,29, endoribonucleaseH,34, cathepsin LI,21, Wnt-3J,17, FZDK,17, LRP6L,17, ezrinM,35, ADRPN,33, NRP1O,36, EP300P,11, PTGS2Q,18, HSP90AA1R,11,18, matrix metalloproteinase 9S,26, IL-6T,16,30, IL-10U,16, VEGFAV,30, and RELAW,30 proteins. In Vitro studies demonstrate efficacy in Calu-3X,43, A549Y,16, HEK293-ACE2+Z,50, Huh-7AA,20, Caco-2AB,42, Vero E6AC,14,37,42, mTECAD,45, and RAW264.7AE,45 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAF,47, db/db miceAG,45,53, BALB/c miceAH,52, and rats57. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice52.
Xu et al., 5 Sep 2023, peer-reviewed, 7 authors. Contact: huangluqi01@126.com.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease
Haiyu Xu, Yute Zhong, Jinyue Yang, Lifeng Fu, Yi Shi, Luqi Huang, George F Gao
Proceedings of the National Academy of Sciences, doi:10.1073/pnas.2309870120
Recently, we published an article (1) showing that several bioactive compounds were identified from Huashi Baidu decoction (Q-14) that showed both antiviral activity and antiinflammatory effects against COVID-19. The main protease (M pro ) of SARS-CoV-2 is an attractive target for the development of antiviral drugs. Our results showed that quercetin and echinatin from Q-14 displayed moderate inhibition activities against SARS-CoV-2 M pro at submicromolar levels by the fluorescence resonance energy transfer (FRET)-based protease activity assay. However, Yan et al. suggested that quercetin is a promiscuous M pro inhibitor because of its fluorescence quenching effect (2). We took this suspicion very seriously. Therefore, we repeated the FRET-based protease activity assay and tested the fluorescence quenching effects with the MCA-AVLQ-Lys (Dnp)-Lys-NH2 (MCA-AVLQ) fragment. The FRET assay results showed that both quercetin and echinatin have M pro inhibition activity (Fig. 1 A and E ), but both quercetin and echinatin displayed a fluorescence quenching effect on MCA-AVLQ fragment (Fig. 1 B and F ). The inhibition ratio and quenching ratio were further calculated (Fig. 1 C and G). We found that the inhibition ratio is significantly greater than the quenching rate, especially at low concentrations, which indicates that quercetin and echinatin should possess certain M pro inhibition activity. To further validate the M pro inhibition activity of
References
Xu, Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19, Proc. Natl. Acad. Sci. U.S.A
Yan, Production of a versatile SARS-CoV-2 main protease biosensor based on a dimerization-dependent red fluorescent protein, J. Med. Virol
Yan, Zhang, Liu, Wang, Chen, Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease, Proc. Natl. Acad. Sci. U.S.A
{ 'indexed': {'date-parts': [[2023, 9, 6]], 'date-time': '2023-09-06T05:09:07Z', 'timestamp': 1693976947450}, 'reference-count': 0, 'publisher': 'Proceedings of the National Academy of Sciences', 'issue': '37', 'license': [ { 'start': { 'date-parts': [[2023, 9, 5]], 'date-time': '2023-09-05T00:00:00Z', 'timestamp': 1693872000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': ['www.pnas.org'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2023, 9, 12]]}, 'DOI': '10.1073/pnas.2309870120', 'type': 'journal-article', 'created': {'date-parts': [[2023, 9, 5]], 'date-time': '2023-09-05T17:52:22Z', 'timestamp': 1693936342000}, 'update-policy': 'http://dx.doi.org/10.1073/pnas.cm10313', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor ' 'against SARS-CoV-2 main protease', 'prefix': '10.1073', 'volume': '120', 'author': [ { 'given': 'Haiyu', 'family': 'Xu', 'sequence': 'first', 'affiliation': [ { 'name': 'Institute of Chinese Materia Medica, Academy of Chinese Medical ' 'Sciences, Beijing 100700, China'}]}, { 'given': 'Yute', 'family': 'Zhong', 'sequence': 'additional', 'affiliation': [ { 'name': 'Institute of Chinese Materia Medica, Academy of Chinese Medical ' 'Sciences, Beijing 100700, China'}]}, { 'given': 'Jinyue', 'family': 'Yang', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chinese Academy of Sciences Key Laboratory of Pathogen ' 'Microbiology and Immunology, Institute of Microbiology, Chinese ' 'Academy of Sciences, Beijing 100101, China'}]}, { 'given': 'Lifeng', 'family': 'Fu', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chinese Academy of Sciences Key Laboratory of Pathogen ' 'Microbiology and Immunology, Institute of Microbiology, Chinese ' 'Academy of Sciences, Beijing 100101, China'}]}, { 'given': 'Yi', 'family': 'Shi', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chinese Academy of Sciences Key Laboratory of Pathogen ' 'Microbiology and Immunology, Institute of Microbiology, Chinese ' 'Academy of Sciences, Beijing 100101, China'}]}, { 'given': 'Luqi', 'family': 'Huang', 'sequence': 'additional', 'affiliation': [ { 'name': 'State Key Laboratory of Dao-di Herbs, National Resource Center ' 'for Chinese Materia Medica, China Academy of Chinese Medical ' 'Sciences, Beijing 100700, China'}]}, { 'ORCID': 'http://orcid.org/0000-0002-3869-615X', 'authenticated-orcid': False, 'given': 'George F.', 'family': 'Gao', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chinese Academy of Sciences Key Laboratory of Pathogen ' 'Microbiology and Immunology, Institute of Microbiology, Chinese ' 'Academy of Sciences, Beijing 100101, China'}]}], 'member': '341', 'published-online': {'date-parts': [[2023, 9, 5]]}, 'container-title': 'Proceedings of the National Academy of Sciences', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://pnas.org/doi/pdf/10.1073/pnas.2309870120', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 9, 5]], 'date-time': '2023-09-05T17:52:43Z', 'timestamp': 1693936363000}, 'score': 1, 'resource': {'primary': {'URL': 'https://pnas.org/doi/10.1073/pnas.2309870120'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 9, 5]]}, 'references-count': 0, 'journal-issue': {'issue': '37', 'published-print': {'date-parts': [[2023, 9, 12]]}}, 'alternative-id': ['10.1073/pnas.2309870120'], 'URL': 'http://dx.doi.org/10.1073/pnas.2309870120', 'relation': {}, 'ISSN': ['0027-8424', '1091-6490'], 'subject': ['Multidisciplinary'], 'container-title-short': 'Proc. Natl. Acad. Sci. U.S.A.', 'published': {'date-parts': [[2023, 9, 5]]}, 'assertion': [ { 'value': '2023-09-05', 'order': 2, 'name': 'published', 'label': 'Published', 'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit